# Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study.

> **NCT03345290** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 92 (actual)

## Conditions studied

- Aging Disorder

## Interventions

- **DEVICE:** PET with a cerebral step
- **DEVICE:** Central blood pressure measurement
- **OTHER:** Neurocognitive tests

## Key facts

- **NCT ID:** NCT03345290
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-31
- **Primary completion:** 2020-11-06
- **Final completion:** 2020-11-06
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345290, "Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03345290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*